Pulmonary Embolism Current Events | Pulmonary Embolism News | 4
|
| Page
4 of
14 |
275 Results |
|
|
|
Sort By:
Page Views | Date |
Drug for erectile dysfunction improves heart function in young heart-disease patients
Heart function significantly improved in children and young adults with single-ventricle congenital heart disease who have had the Fontan operation following treatment with sildenafil, a drug used to treat erectile dysfunction and pulmonary hypertension, say researchers from The Children's Hospital of Philadelphia. view more (2009-11-19)
African-Americans have unique lung cancer risks from chronic obstructive pulmonary disease
Scientists at the M.D. Anderson Cancer Center have developed a risk prediction assessment for lung cancer specifically for African Americans that suggests a greater risk from chronic obstructive pulmonary disease (COPD). view more (2008-09-05)
Against pulmonary fibrosis
The biotech companies Digna Biotech and Biotherapix have signed an agreement to jointly apply their patented products towards the development of a treatment for pulmonary fibrosis. view more (2006-03-06)
Mountain Climbers Vulnerable To Subclinical Lung Disorder (pp 276, 303)
Three out of four recreational climbers could be at risk of a mild form of the lung disorder called high altitude pulmonary oedema, conclude authors of a study in this week's issue of THE LANCET. High altitude pulmonary oedema (HAPE) is characterised by increased pulmonary artery pressure which leads to accumulation of fluid in the lungs. Severe... view more... (2002-01-23)
Anti-cancer drug shows early promise in pulmonary hypertension
A drug used to treat kidney cancer can prevent the development of pulmonary hypertension (high blood pressure in the lungs) in rodents. view more (2006-11-15)
ESC Congress: Task Force on the Management of Cardiovascular Diseases during Pregnancy
IMPORTANT: This press release accompanies a presentation given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology Most pregnant women have normal hearts and most patients with heart disease are not contemplating pregnancy so many... view more... (2003-09-03)
Canadian study demonstrates medical induction of labor increases risk of amniotic-fluid embolism
A Canadian population-based cohort study has revealed that medical induction of labour increases the risk of amniotic-fluid embolism. view more (2006-10-23)
Extra-aggressive form of idiopathic pulmonary fibrosis identified
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disorder from which most patients die within 5 years after diagnosis. The disease is characterized by the insidious onset of dyspnea or cough and usually evolves slowly. view more (2007-05-30)
New guidelines help clinicians assess risk of post-surgical pulmonary complications
Pulmonary complications, including pneumonia and respiratory failure, are a common - and dangerous - problem for patients following major surgery. view more (2006-04-19)
Decision-making by residents on-call has 'miniscule' negative impact on patient care
The study consisted of the review of approximately 12,000 emergency diagnostic imaging exams that were interpreted after hours by residents. view more (2007-09-24)
Afib triggered by a cell that resembles a pigment-producing skin cell
The source and mechanisms underlying the abnormal heart beats that initiate atrial fibrillation (Afib), the most common type of abnormal heart beat, have not been well determined. view more (2009-10-13)
ESC Congress 2003: Sudden cardiac death - New drug therapies improve outcome
IMPORTANT: This press release accompanies both a presentation and an ESC press conference given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology ESC Congress 2003: Cold comfort - cough for your life Sudden cardiac death is mostly... view more... (2003-09-02)
Researchers develop gene therapy to reverse pulmonary arterial hypertension
A University of Alberta research team has discovered important new information they hope will lead to more effective treatments for pulmonary arterial hypertension (PAH)-a deadly form of high blood pressure in the pulmonary arteries caused by uncontrolled cell growth. view more (2005-06-03)
Obesity strongly linked to pulmonary embolism and deep venous thrombosis
Since 1927, obesity has been thought to be a risk factor for fatal pulmonary embolism (PE). Because of the high proportion of obesity in the general population, previous studies have not determined whether obesity is an independent risk factor for PE or deep venous thrombosis (DVT). view more (2005-09-09)
Annual study finds top hospitals have 28 percent lower mortality rate
Patients treated at top-rated hospitals nationwide have nearly a one-third better chance of surviving, on average, than those admitted to all other hospitals, according to a study released today by HealthGrades, the leading independent healthcare ratings company. view more (2007-01-30)
Translational research patented first experimental treatment against idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis is a disease with unknown cause with a very severe prognosis; when detected, it is already in an advanced stage. view more (2007-12-26)
A candidate gene for familial idiopathic pulmonary fibrosis identified
ELMOD2-gene is a prime candidate gene for familial idiopathic pulmonary fibrosis, suggests the recent study published by the researchers at the University and University Hospital of Helsinki, Finland. view more (2006-06-29)
New Emergency Drug for Cardiac Arrest
Vasopressin as an agent for cardio-pulmonary resuscitation Diseases of the cardiovascular system continue to be the most frequent causes of death in the Western world. For over 100 years, Adrenaline has been the standard drug of choice in the treatment of sudden cardiac arrest. A team of researchers headed by Karl H. Lindner and Volker Wenzel... view more... (2002-09-30)
COPD patients benefit more from pulmonary rehab in earlier stages
Patients with chronic obstructive pulmonary disease (COPD) who are in their final years of survival do not get the same benefits from pulmonary rehabilitation (PR) as patients who have more years left to live-regardless of their age, complicating illnesses or lung function. view more (2008-05-20)
Preventing lung scarring may extend lives of lung cancer patients
Researchers have found that using a special type of drug called a pharmaceutical monoclonal antibody to block the integrin beta6-TGF-beta pathway prevents a serious side effect of radiation therapy for lung cancer patients - pulmonary fibrosis (scarring of the lungs), thereby extending patients' lives and improving their quality of life. view more (2007-10-30)
|
|
| Page
4 of
14 |
275 Results |
|
|
|
Sort By:
Page Views | Date |
|
